Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission-Reference-Cited by-同舟云学术

Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission

Published:2017-09-28 Issue:12 Volume:92 Page:1318-1323
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Gorin Norbert-Claude¹^ORCID,Labopin Myriam¹,Pabst Thomas²,Remenyi Peter³,Wu Depei⁴,Huynh Anne⁵,Volin Liisa⁶,Cahn Jean Yves⁷,Yakoub-Agha Ibrahim⁸,Mercier Melanie⁹,Houhou Mohamed¹,Mohty Mohamad¹,Nagler Arnon¹¹⁰,

Affiliation:

1. Department of Hematology and Cell Therapy and EBMT Paris Office; Hôpital Saint-Antoine APHP, INSERM U 938, Université Pierre et Marie Curie UPMC; Paris France

2. Department of Oncology; University Hospital Bern; 3010 Bern Switzerland

3. Department of Hematology and Stem Cell Transplant; Saint István and Saint Laszlo Hospital, Semmelweis University; Budapest Hungary

4. Department of Hematology; First Affiliated Hospital of Soochow University; 215006 Suzhou Jiangsu China

5. Institut Universitaire du Cancer Toulouse, Oncopole, I.U.C.T-O; 31059 Toulouse France

6. HUCH Comprehensive Cancer Center Stem Cell Transplantation Unit; Helsinki Finland

7. CHU Grenoble Alpes, Hématologie Clinique; Grenoble France

8. CHU de Lille, LIRIC INSERM U995, Université Lille2; France

9. Centre Hospitalo Universitaire, Inserm U898; Angers France

10. Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, EBMT ALWP Chair; Tel Hashomer Israel

Publisher

Wiley

Subject

Hematology

Reference26 articles.

1. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study;Terwijn;J Clin Oncol.,2013

2. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia;Al-Mawali;Am J Clin Pathol.,2009

3. Introducing minimal residual disease in acute myeloid leukemia;Ofran;Curr Opin Hematol.,2015

4. Assessment of minimal residual disease in standard-risk AML;Ivey;N Engl J Med.,2016

5. Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation;Campana;Br J Haematol.,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching study;Hematological Oncology;2023-09-26

2. Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT;Bone Marrow Transplantation;2023-08-28

3. Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation;Bone Marrow Transplantation;2021-11-13

4. Optimizing Autologous Hematopoietic Stem Cell Transplantation for Acute Leukemia;Stem Cells Translational Medicine;2021-11-01

5. Consolidation: Autologous Stem Cell Transplantation in Acute Leukemia;Acute Leukemias;2021-03-24